SCHEMBL23090397

SCHEMBL23090397

Cc1cc(CC2=CCCCC2)cc(Cc2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
HTR1A P08908 1/20 0.40
HTR7 P34969 1/20 0.40
HTR6 P50406 1/20 0.40
EPHX1 P07099 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
NPSR1 Q6W5P4 4/20 0.38
MAPT P10636 3/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
CALM1 P0DP23 1/20 0.36
CXCR3 P49682 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30513715 1.00 ALDH1A1 (0.41) ALDH1A1HPGDHTR1AHTR7HTR6
Cyclohexane SCHEMBL21494734 0.98 ALDH1A1 (0.40) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL1399903 0.85 ALDH1A1 (0.50) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL112394 0.84 ALDH1A1 (0.49) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL8206338 0.84 ALDH1A1 (0.49) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL6806443 0.84 ALDH1A1 (0.49) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL111084 0.84 ALDH1A1 (0.49) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL30513714 0.83 DAO (0.45) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL21494727 0.83 DAO (0.45) ALDH1A1HPGDHTR1AHTR7HTR6
SCHEMBL28561920 0.82 ALDH1A1 (0.48) ALDH1A1HPGDHTR1AHTR7HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138121-A1 SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS CHEVRON U S A INC (US) 2026-05-21 US disclosed
US-12269018-B2 Platinum-sulfur-based shell catalyst, production and use thereof in the dehydrogenation of hydrocarbons CLARIANT INTERNATIONAL LTD (CH) 2025-04-08 US disclosed
US-20250065311-A1 SULFIDATED NOBLE METAL ON METAL DOPED SUPPORT AS A HYDROGENATION AND DEHYDROGENATION CATALYST CHEVRON USA INC (US) 2025-02-27 US disclosed
CN-111989156-B Shell catalyst based on platinum-sulphur, production and use in hydrocarbon dehydrogenation 科莱恩国际有限公司 2023-08-11 CN disclosed
US-20210077984-A1 PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS CLARIANT INTERNATIONAL LTD (CH) 2021-03-18 US disclosed
CN-111989156-A Platinum-sulfur based shell catalysts, their production and use in the dehydrogenation of hydrocarbons 科莱恩国际有限公司 2020-11-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260138121-A1 SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS NUDC, SOD1, TIMM10 ALDH1A1 1139/4885HPGD 1516/4885HTR1A 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.